Pediatrix Medical Group (MD) Proxy filing summary

Executive summary

• Annual meeting scheduled for May 7, 2026, to be held virtually for shareholders of record as of March 9, 2026.

• Shareholders are encouraged to review proxy materials online and may request paper copies by April 27, 2026.

Voting matters and shareholder proposals

• Election of nine directors for terms expiring at the next annual meeting or until successors are elected.

• Ratification of PricewaterhouseCoopers LLP as independent auditor for fiscal year 2026.

• Advisory vote on executive compensation for the 2025 fiscal year.

• Approval of the Second Amended and Restated 2008 Incentive Compensation Plan.

• Consideration of other business that may properly come before the meeting.

Board of directors and corporate governance

• Nine director nominees listed, including Laura A. Linynsky, Thomas A. McEachin, Kurt D. Newman, M.D., Mark S. Ordan, Michael A. Rucker, Guy P. Sansone, John M. Starcher, Jr., Shirley A. Weis, and Sylvia J. Young.